Daniel Schneiderman - 03 Jan 2022 Form 4 Insider Report for First Wave BioPharma, Inc. (FWBI)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Daniel H. Schneiderman
Issuer symbol
FWBI
Transactions as of
03 Jan 2022
Transactions value $
$0
Form type
4
Filing time
03 Jan 2022, 20:07:07 UTC
Previous filing
02 Jul 2021
Next filing
15 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FWBI Stock option (right to buy) Award $0 +10K $0.00 10K 03 Jan 2022 Common stock, par value $0.0001 per share 10K $1.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Schneiderman's continued employment by First Wave BioPharma, Inc. on the applicable vesting date.